Cytomegalovirus Treatment Market is Expected to Proliferate at a CAGR of over 6% through 2028 | FMI

The cytomegalovirus treatment market is poised to grow at an impressive y-o-y of over 5.5% in 2019, as per the latest research study published by FMI. A cohort of macro factors, including rapid adoption of innovative treatment procedures and burgeoning investments in healthcare, are auguring well for the wide-spread adoption of cytomegalovirus treatment. These insights are per the latest FMI research study that conveys a healthy outlook for global cytomegalovirus market in 2019 and beyond.

Patient pool affected by cytomegalovirus is on a consistent rise, necessitating adoption of effective treatment methods and therapies. As per a revelation by the MedlinePlus, between 50 percent and 80 percent of adults in the US have suffered from cytomegalovirus by the age of 40. Statistics as such demonstrate augmented adoption of cytomegalovirus treatment products and procedures in the future, creating sustained opportunities for the manufacturers to reap sizeable revenues.

As per the FMI report, demand for valganciclovir drug continues to be buoyant on account of effective results if taken at evenly spaced intervals, with global sales likely to surpass US$ 55.5 Mn in 2019. In addition to this, valganciclovir is less time-consuming and affordable, which is further adding to its popularity in the cytomegalovirus treatment space.

“The drug development framework for treatment of cytomegalovirus continues to be progressive, offering ample scope for development of new products and procedures. There are multiple clinical trials being performed for cytomegalovirus treatment worldwide, led by prominent regions including Europe and North America. The late-stage pipeline comprises exceptional drugs which are envisioned to enter the market. This, in turn, is likely to create favorable scenario for cytomegalovirus treatment market over the forecast period”, says FMI report.

Hospital Pharmacies Remain Highly Lucrative Channel for Manufacturers with Notable ROI Benefits

As per the report, congenital CMV infection registers substantial demand for cytomegalovirus treatment, with global sales expected to surpass over US$ 65.5 Mn in 2019. Hospital pharmacies are likely to steer sales of cytomegalovirus treatment products and procedures, owing to reliable offerings at reasonable costs. The well-informed and modern patients seek a combination of efficiency with convenience, which is making e-commerce a rapidly growing distribution channel for manufacturers to commercialize their offerings.  

As per the report, high cost of cytomegalovirus treatment procedures remains a key factor hampering adoption and deterring market’s growth potential. Along with high prices, associated side effects of cytomegalovirus treatment products and procedures are denting end-user confidence. Some of the prevalent side effects associated with cytomegalovirus treatment products and procedures include neutropenia, nausea, thrombocytopenia, hematological toxicity, renal dysfunction, and so on.

Manufacturers in the cytomegalovirus treatment market are focusing on novel developments, resulting in upgraded products with ameliorated functionalities. The market players are also focusing on product availability in varying size dimensions for increased convenience of end-users. The cytomegalovirus treatment market is witnessing a series of strategic partnerships, acquisitions, and mergers, which enables the manufacturing companies to offer viable offerings by combining their production expertise. For instance, Johnson & Johnson completed the acquisition of Ci:z Holdings Co., Ltd. in 2019 for expanding its exclusive portfolio of science-based dermocosmetic beauty products.

The FMI report profiles prime opportunities in the cytomegalovirus treatment market for the forecast period of 2018 to 2028. According to the report, the cytomegalovirus treatment market is expected to proliferate at a CAGR of over 6% through 2028.

Press Release Source: https://www.prnewswire.com/news-releases/cytomegalovirus-treatment-market-expected-to-behold-a-cagr-of-6-through-2018—2028-300788851.html

ABOUT US:

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

CONTACT:

Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Latest News

Springboks' 1st black captain gets his chance at history

Apr 3, 2020

TOKYO — It was the week after Siya Kolisi's fourth birthday when Nelson Mandela presented Springboks captain Francois Pienaar with the Webb Ellis Cup in a defining moment for rugby, and for South Africa. Kolisi was 16 when the Springboks won their second Rugby World Cup title. There was no television at his home, he recalls, so he had to go to a tavern to watch John Smit lift the trophy after beating England in the 2007 final in Paris. Twelve years on, the first black player appointed as Springboks captain gets a chance to etch his name in history...

England's response to All Blacks haka results in fine

Apr 3, 2020

TOKYO — England has been fined for crossing the halfway line in its response to New Zealand's pre-match haka at the Rugby World Cup semifinals. World Rugby says England breached "tournament rules relating to cultural challenges, which states that no players from the team receiving the challenge may advance beyond the halfway line." England's players stood in a V-formation as the All Blacks performed the haka, with a half-dozen players beyond the halfway line. World Rugby says the sanction is in line with protocol that operates across the international game. The fine is reported to be 2,500 pounds ($3,200) ___...

The Latest: Scott Barrett into backrow in NZ's only change

Apr 3, 2020

TOKYO — The Latest on Thursday at the Rugby World Cup in Japan (all times local): 11:30 a.m. Scott Barrett will start in the backrow in the only change to New Zealand's starting XV for the Rugby World Cup semifinal against England. The versatile Barrett replaces Sam Cane on the blindside flank as the All Blacks bid to bolster the lineout. Barrett replaced Cane in a tactical change at halftime in New Zealand's 46-14 win over Ireland in the quarterfinals last weekend. He will join brother, fullback Beauden Barrett, in the starting XV. Another brother, Jordie Barrett, is on the...

Sharp-talker Jones says spy filmed England, lobs barbs at NZ

Apr 3, 2020

TOKYO — It's Rugby World Cup semifinals week and Eddie Jones, one of the sport's sharpest talkers, is in full wind-up mode. The team bearing the brunt of the England coach's barbs? England's opponent on Saturday, the world champion All Blacks. The All Blacks' mental skills coach will be "the busiest bloke in Tokyo," Jones said Tuesday. He described New Zealand's journalists as "fans with laptops." He spoke of "omens" in the week of Japan's enthronement of a new emperor. He even made accusations of spying. "There was definitely someone in the apartment block, filming," Jones claimed after England's morning...

Lomu's legacy looms over NZ-England World Cup semifinal

Apr 3, 2020

TOKYO — One trampling run launched Jonah Lomu to global stardom, ensuring his name will be indelibly linked to a Rugby World Cup semifinal between New Zealand and England. The All Blacks winger's rampaging runs during that era-defining World Cup in South Africa in 1995 were highlighted by his four-try haul against England in the semifinals. Before the teams meet in another semifinal this Saturday in Yokohama, there'll be no avoiding remembrances of Lomu's legacy. He died in 2015 at the age of 40 after complications from a kidney disease. One of those tries against England, when he gathered a...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!